Skip to main content

Advertisement

Table 1 Cardiac function-related parameters in different groups $$ \left(\overline{x}\pm \mathrm{s}\right) \)

From: Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway

Group N Sham Model Danqi pill Positive drug
LV Mass (ug) 12 647.29 ± 206.658** 936.29 ± 203.356 803.33 ± 213.294 872.65 ± 137.586
IVS;d (cm) 12 1.986 ± 0.316** 1.402 ± 0.378 1.532 ± 0.500 1.190 ± 0.380
IVS;s(cm) 12 2.915 ± 0.592 ** 1.658 ± 0.684 2.050 ± 0.886 1.476 ± 0.539
LVEDd(cm) 12 5.735 ± 0.656** 8.741 ± 1.2054 7.777 ± 1.869 9.107 ± 1.138
LVED;s(cm) 12 2.988 ± 0.829 ** 7.059 ± 1.535 5.746 ± 2.502* 7.538 ± 1.519
LVPWd(mm) 12 2.030 ± 0.441** 2.012 ± 0.389 1.953 ± 0.392 1.852 ± 0.361
LVPWs(mm) 12 2.758 ± 0.598** 2.792 ± 0.481 2.254 ± 0.618 2.560 ± 0.618
EF (%) 12 78.274 ± 10.514** 41.388 ± 17.238 52.375 ± 24.421** 34.823 ± 14.849
FS(%) 12 48.826 ± 10.557** 21.882 ± 10.552 30.241 ± 17.328** 17.905 ± 8.367
  1. *P < 0.05, **P < 0.01, Levels in the model group were used as reference to calculate P values.